Novo Nordisk shares slide after guidance disappoints investors
CNBC Stocks· Aug 4, 2026 · 6:08 PM
Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
This is a summary. Read the complete story at CNBC Stocks below.
Read full article at CNBC Stocks
